French developer of "peanut allergy patch" makes U.S. debut
October 22, 2014 at 04:06 AM EDT
PARIS, Oct 22 (Reuters) - French biotech firm DBV Technologies - developer of what it says is a breakthrough treatment for peanut allergy sufferers - makes its U.S. market debut on Wednesday, with a Nasdaq listing set to raise funds for further research.
